Health·3,522 stories
This week's Health & Science stories trace a widening gap between what medicine discovers and what patients actually receive. While Moderna's mRNA cancer vaccine scores a Phase III win and Regeneron's FOP drug cuts lesions by 94%, Capricor's Duchenne therapy heads for FDA rejection and focal therapy reaches just 1.3% of eligible U.S. prostate cancer patients. Three pillars of medical consensus — depression shrinking the hippocampus, longevity requiring protein restriction, Greek centenarians revealing the secrets of long life — collapsed under scrutiny in the same stretch.
Regeneron's Pasatru won FDA approval with a 94% reduction in new lesion formation for FOP patients, but Capricor's deramiocel is heading for rejection because extension data cannot rescue a failed Phase 3 trial. Moderna's mRNA cancer vaccine posted its first Phase III win at an estimated $200,000 per course, and focal therapy for localized prostate cancer matches 10-year survival of standard treatment yet reaches only 1.3% of eligible U.S. patients despite Medicare coverage. Cancer medicine produced more genuine breakthroughs in 2025 than any year in memory, and delivered them to fewer people.
Drought is being reframed from a water-supply crisis into a disease-emergence crisis, with peer-reviewed work linking specific drought patterns to outbreak geography. Lone star ticks push north and west with climate change and reforestation, carrying two emerging viruses with no commercial tests into more U.S. exposure zones. Communities near shuttered coal plants and inside clean air zones are showing measurable cardiovascular benefits within years. Epidemiology is now downstream of meteorology, and public health is reacting on a policy-cycle lag.
The decade-old claim that depression physically shrinks the hippocampus does not hold up under fresh analysis, undermining the anatomical basis long cited for cognitive symptoms. Greece's centenarian records — the bedrock of every demographic model projecting future life expectancy and every clinical target for life-extension therapies — were fraudulent. Experts have rejected protein restriction as a longevity strategy despite its grip on aging research. Medical conventional wisdom is more fragile than the institutions built on it assumed.
The global health aid architecture is collapsing, with the $2 billion faith-economy award concentrating on Christian delivery organizations in 17 countries and depending on U.S. appropriations that are no longer reliable. The Channel 4 ADHD documentary — broadcast under NICE guidelines used across the NHS — was called unscientific by Rippon, threatening public understanding of a diagnosis that controls treatment access for millions. The vetting, funding, and communication systems that translate medicine into public health practice are losing credibility at the same time the underlying science is accelerating.
Trump's final GLOBE Medicare drug pricing rule covers only four companies, slashing estimated savings from nearly $12 billion to $440 million — a 96% drop driven by exemptions for voluntary Medicaid d
A federal judge let CalPERS's investor lawsuit against UnitedHealth partially proceed over allegations the company inflated 2024 earnings by $3.3 billion to mask Medicare Advantage weakness, while tos
HHS announced a five-year program called SURPASS, run through ARPA-H, that will use AI and computational models to accelerate clinical trials by replacing sharply delineated trial phases with seamless
New Scientist Book Club members mostly loved Chanda Prescod-Weinstein's 'The Edge of Space-Time,' calling it a 'wild ride' through quantum physics and black holes, though some Discord readers pushed b
Psychologist Kimberley Wilson argues that modern healthcare must integrate lifestyle, social, and whole-body factors rather than relying on a pharmaceutical-first model that has failed to stem rising
The One Big Beautiful Bill Act will strip Medicaid coverage from more than 281,000 lawfully present immigrants across nine states starting in October, hitting refugees, asylees, sex-trafficking victim
Researchers from the Universities of Exeter and Essex have found that butterfly wing patterns combined with fluttering flight create motion illusions that scramble predators' sense of speed and direct
An Eli Lilly combination of GLP-1 drug Zepbound and amylin-targeting eloralintide produced 23.3% weight loss at the highest dose after 48 weeks in a mid-stage trial in patients with obesity and type 2
An AP/KFF poll of more than 2,000 rural registered voters found that about 8 in 10 — including 68% of MAHA supporters — say Trump administration health policies have had negative or no impact on their
A King's College London review of 63 studies covering more than 265,000 people found cannabis users were roughly twice as likely to commit violent acts and about 1.5 times as likely to be victims of v
Stanford professor Sergiu Pașca's team published in Nature a mouse with a cortex made of human brain cells, prompting a STAT+ opinion piece to question what such a chimera means for intelligence and c
Former Commerce Secretary Gary Locke and former Rep. Patrick McHenry argue Washington must invest in domestic biotech capabilities rather than rely on restrictions to counter China's accelerating biom
A police watchdog has criticised Norfolk Police after 101 call handlers told parents worried about their mentally ill son to ring a locksmith; the 30-year-old was found dead the next day following a s
A 12-week Texas A&M study found that daily creatine helped middle-aged adults gain lean tissue and strength even without a structured exercise program, and when combined with workouts and a calorie de
Curated health stories, every morning. Free.
No spam. Unsubscribe anytime.